BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

2.070

-0.020 (-0.96%)

At close: Dec 5, 2025, 4:00 PM EST

2.030

-0.040 (-1.93%)

After-hours: Dec 5, 2025, 7:48 PM EST

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $45.27 million as of December 5, 2025. Its market cap has increased by 75.71% in one year.

Market Cap

45.27M

Enterprise Value

118.38M

1-Year Change

75.71%

Ranking

#4630

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $45.27M, a decrease of -73.77%. That is a compound annual growth rate of -15.86%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	45.27M	143.96%
Dec 31, 2024	18.56M	-78.51%
Dec 29, 2023	86.35M	-85.65%
Dec 30, 2022	601.94M	5.82%
Dec 31, 2021	568.84M	-49.47%
Dec 31, 2020	1.13B	327.27%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	904.62B
Johnson & Johnson	486.51B
AbbVie	399.57B
UnitedHealth Group	299.75B
AstraZeneca	280.82B
Novartis AG	255.15B
Merck & Co.	247.51B
Abbott Laboratories	217.50B

Market Cap Rankings